InPress Media Group, LLC

01/08/2026

Conference Coverage

03/20/2024

Listen to the latest episodes of The Onco'Zine Brief

The Onco'Zine Brief is an interview and discussion program presented by Peter Hofland and covers a broad range of topics and timely news updates with information from all oncology disciplines and sub-specialties from around the world. The Onco'Zine Brief is a sponsor-supported, program for healthcar...

08/17/2023

Join Stand Up To Cancer as we celebrate 15 years of groundbreaking cancer research on August 19, 2023 at 8 ET / 7 Central.
https://standuptocancer.org/su2c-show-2023/

08/17/2023

While pricing controls imposed by the Inflation Reduction Act of 2022 (IRS) may appear positive for patients in the short term, and is considered a step forward in improving affordability of, and access to, innovative medical treatments, these controls may have unintended consequences on biopharmaceutical drug development programs and investments in the long term unless this pressure is offset by the opportunity to modernize the way clinical trials are conducted.

The Inflation Reduction Act of 2022 (IRA) covers new and reinstated tax laws that will affect individuals and businesses. Through IRA, President Biden delivered on his promise to lower prescription drug costs by allowing, for the first time, the U.S. Centers for Medicare & Medicaid Services (CMS) to...

03/17/2023

Listen to The Onco'Zine Brief - in Episode 101 Peter Hofland talks with Dr. Matthias Bucerius.

Podcast versions: https://lnkd.in/gx5rP97K
PRX | Public Radio Exchange https://lnkd.in/gg_wJQT2-
UK health Radio: https://ukhealthradio.com/blog...

01/20/2023

https://exchange.prx.org/p/458032 or https://bit.ly/TOB-Jan_16_2023

In the 100th episode of the Onco'Zine Brief, Peter Hofland, Ph.D. talks with Stephen Spellman, Vice President of Research and Senior Scientific Director of the Center for International Blood and Marrow Transplant Research at the National Marrow Donor Program/Be the Match.

In the program today Hofland and Spellman talk about bone-marrow transplants.

The likelihood of finding a fully matched unrelated donor for a patient who needs a bone marrow transplant varies greatly depending on a patient's ethnic background, and that ethnically diverse patients have – historically – been at a disadvantage. However, new research shows that when donor registry models are expanded to include mismatched unrelated donors, finding access for patients may greatly improve.[1]

Based on this understanding, Spellman believes that mismatched unrelated donors hold the key to erasing the gap in donor availability and deliver allogeneic hematopoietic cell transplantation (HCT) to all patient populations.

About The Onco'Zine Brief
The Onco'Zine Brief is distributed in the United States via PRX (Public Radio Exchange). In the United Kingdom and Europe, the program is distributed via UK Health Radio (UKHR). And the program can be downloaded via most podcasts and streaming media services, including iTunes, Spotify, TuneIn, and iHeart Radio.

For more information about The Onco'Zine Brief or how to sponsor or support this public radio broadcast and podcast, download our Media Kit https://lp.constantcontactpages.com/su/jj9JqsS/MediaKit202122/ , visit Patreon at https://www.patreon.com/theoncozinebrief or contact the sales team at https://www.oncozine.com/advertisement-sponsorship-options/

For more information about cancer and cancer treatments, visit our online journal Onco'Zine at www.oncozine.com

To sign up for The Onco'Zine Newsletter (open for residents of the United States only), text the word CANCER to 66866.

The Onco’Zine Brief is made possible, in part, by Java Original Coffee – the home of artisan roasted coffee. Order no at www.javaoriginalcoffee.com

Reference
[1] Spellman S. Is finding a Donor for All in Need of Allogeneic HCT Possible? New Modeling Says Yes - Onco'Zine on September 5, 2022.

https://exchange.prx.org/p/458032 or https://bit.ly/TOB-Jan_16_2023

10/21/2021

11/22/2019

10/02/2019

Design of Experiments (DoEs) are a specific application of statistical techniques to enable rapid and robust development. Those techniques can be directed towards factor screening or process robustness depending on the specific needs of the project phase. Often these experiments result in a stronger process understanding, while requiring less time and fewer material resources. Watch the Presentation On Demand.

https://adc.expert/NovasepDOE

08/24/2019

Researchers at Ludwig Cancer Research have uncovered a novel vulnerability in tumors that are driven by a common cancer gene known as MYC, which is part of a family of regulator genes and proto-oncogenes that code for transcription factors. The researchers found that these cancers are highly depende...

05/21/2019

It’s no secret that the opioid crisis plaguing America is more dire than ever. Dramatic increases in both the misuse of prescription opioids and the use of illegal opioids [1][2] have yielded an addiction epidemic, hundreds of thousands of deaths and billions of dollars in healthcare costs. Today,...